- Dr. Dan Douer of MSKCC presented data at the 2012 Chemotherapy Foundation Symposium from a pivotal Phase 2 RALLY trial of Marquibo. Marqibo is indicated for the treatment of adult patients with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.
- The New Times reports that MSKCC has agreed to train Rwandan public and private medical personnel on cancer treatment and management.